Acute hepatic porphyrias in Mexico: A tale of challenges and achievements facing rare diseases.

Worldwide, patients with porphyrias face critical delays in diagnosis. In Mexico this situation is no exception and, due to the characteristics of the local health system, population distribution and lack of access to health services and specialized porphyria centers, diagnosis and treatment are complex. Much work remains to be done, in collaboration with government authorities, physicians, advocacy groups and the pharmaceutical industry, to provide knowledge, diagnostic tools and targeted therapies to all porphyria patients in need.